Company Filing History:
Years Active: 2018
Title: Alan Boyle - Innovator in Biomarker Research
Introduction
Alan Boyle is a distinguished inventor based in Menlo Park, California. He has made significant contributions to the field of biomarker research, particularly in the context of regulatory dysfunction in diseases. His innovative work has the potential to enhance diagnostic methods and disease risk assessments.
Latest Patents
Alan Boyle holds a patent for a method and system for the use of biomarkers for regulatory dysfunction in disease. This patent, titled "Method and system for the use of biomarkers for regulatory dysfunction in disease," focuses on measuring the binding of a transcription factor. The invention provides an improved marker for diseases where a transcription factor binding event plays a crucial role. These biomarkers can be utilized in diagnostics and can also help adjust disease risk profiles for healthy individuals, similar to typical genetic variants. He has 1 patent to his name.
Career Highlights
Alan Boyle is affiliated with Leland Stanford Junior University, where he continues to advance his research in biomarker applications. His work is instrumental in bridging the gap between genetic research and practical medical diagnostics.
Collaborations
Throughout his career, Alan has collaborated with notable colleagues, including Konrad Karczewski and Michael P. Snyder. These partnerships have further enriched his research and contributed to the advancement of the field.
Conclusion
Alan Boyle's innovative work in biomarker research exemplifies the impact of scientific inquiry on medical diagnostics. His contributions are paving the way for improved understanding and management of diseases.